Other Content

Correction: Diffuse alveolar hemorrhage


An incorrect brand name was used for a formulation of methyprednisolone in: Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: Diagnosing it and finding the cause Cleve Clin J Med 2008; 75:258–280; doi:10.3949/ccjm.75.4.258. On page 275, in the section on treatment, the second paragraph should read:

“Most experts recommend intravenous methylprednisolone (Solu-Medrol) (up to 500 mg every 6 hours, although lower doses seem to have similar efficacy) for 4 or 5 days, followed by a gradual taper to maintenance doses of oral steroids.”

The online versions of this article have been corrected.

Next Article:

Kidney stones

Related Articles